Peptide-based Infection Therapeutics Market is segmented by Pathogen Target (Bacterial, Viral, Fungal/Others), Modality (Direct Antimicrobials, Host-defense Peptides, Conjugates/Others), Setting (Hospital IV, Outpatient Oral, Topical), and Region, with forecasts covering the period from 2026 to 2036.
Request for Brochure
The most complete guide to Peptide-based Infection Therapeutics Market in 2026